Brief: Pluristem Reports Data From Studies Evaluating PLX-R18 Cells As Treatment For Radiation Damage
25/06/2018 12:53
June 25 (Reuters) - Pluristem Therapeutics Inc PSTI.O :
* PLURISTEM THERAPEUTICS - REPORTED POSITIVE DATA FROM
STUDIES
EVALUATING PLX-R18 CELLS AS TREATMENT FOR RADIATION DAMAGE TO GI
TRACT AND BONE MARROW
* PLURISTEM - DATA FROM STUDIES SUGGESS PLX-R18 POTENTIAL AS
A
MULTI-ORGAN THERAPY FOR ACUTE RADIATION SYNDROME
Source text for Eikon: ID:nGNX7hGTYZ
Further company coverage: PSTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pluri
See all newsBrief: Pluri Chairman And Active Investor Alejandro Weinstein To Acquire Eib Loan, In Strong Vote Of Confidence In The Company
Brief: Ever After Foods Acquires Fishway To Expand Integrated Food Production Technology Platform
NASDAQ RESUMED AT 09:38 AM
NASDAQ RESUMED AT 09:33 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM